M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.071 AUD -1.39% Market Closed
Market Cap: 43.2m AUD

Net Margin
Microba Life Sciences Ltd

-95.3%
Current
-192%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-95.3%
=
Net Income
-14.9m
/
Revenue
15.7m

Net Margin Across Competitors

No Stocks Found

Microba Life Sciences Ltd
Glance View

Market Cap
43.2m AUD
Industry
Health Care

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.

MAP Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-95.3%
=
Net Income
-14.9m
/
Revenue
15.7m
What is the Net Margin of Microba Life Sciences Ltd?

Based on Microba Life Sciences Ltd's most recent financial statements, the company has Net Margin of -95.3%.

Back to Top